Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study

BACKGROUND: To examine the effect of genetic variation in APOE, IDE and IL1B on the response to induced ketosis in the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in subjects with mild to moderate Alzheimer's disease (AD). METHODS: Genotype effects on ADAS-Cog scores...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Samuel T, Poirier, Judes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213220/
https://www.ncbi.nlm.nih.gov/pubmed/21992747
http://dx.doi.org/10.1186/1471-2350-12-137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213220/
https://www.ncbi.nlm.nih.gov/pubmed/21992747
http://dx.doi.org/10.1186/1471-2350-12-137

Ejemplares similares